Spectral Flow Cytometry Special Report
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging new type of coronavirus that is responsible for the COVID-19 pandemic and the unprecedented global health emergency....
BackgroundTargeted sequencing using oncopanels requires comprehensive assessments of accuracy and detection sensitivity to ensure analytical validity. By employing reference materials characterized...
BackgroundOncopanel genomic testing, which identifies important somatic variants, is increasingly common in medical practice and especially in clinical trials. Currently, there is a paucity of...
Blood self-collection or self-sampling devices are in various states of regulatory approval and their utility varies by the amount of blood they can collect, processing requirements by test, and the...
The ToxCast in vitro screening program has provided concentration-response bioactivity data across more than a thousand assay endpoints for thousands of chemicals found in our environment and...
All trans retinoic acid (ATRA) has demonstrated curative activity in acute promyelocytic leukemia (APL), a distinct subtype of acute myeloid leukemia (AML), that is characterized by a chromosomal...
The successful development and commercialization of personalized medicines often necessitate use of companion diagnostics (CDx).
Research and development for potential COVID vaccines and treatments has been at the forefront of the pharmaceutical industry for most of 2020. Because of this, research dedicated to other...
Chief Pathologist John Cochran discusses how clinical trials offer pathologists the opportunity to work at the forefront of diagnostic discovery in this interview from The Pathologist.